COLTENE (CLTN) CMD 2024 Presentation summary

Strategic direction and market positioning

• Focuses on improving and preserving natural teeth through three business units: Dental Improvement, Treatment Auxiliaries, and Infection Control.

• Targets stable, growing dental markets driven by aging populations, digitalization, and consolidation of dental practices.

• Differentiates with innovation in dental aesthetics, endodontics, and infection control, emphasizing authentic outcomes and workflow efficiency.

• Pursues operational excellence via process automation, portfolio simplification, and near-shoring to optimize costs and quality.

• Aims to be the market leader in North America for infection control and expand in Asia and LATAM through local initiatives.

Value proposition and go-to-market approach

• Dental Improvement offers authentic smile enhancement and tooth preservation, making treatments more attractive than surgery.

• Treatment Auxiliaries provide easy-to-use, efficient tools with a focus on best price/performance and dealer partnerships.

• Infection Control delivers comprehensive, cloud-based sterilization solutions, targeting leadership in North America and niche markets elsewhere.

• Employs both pull (direct sales, marketing) and push (dealer partnerships) strategies tailored to each business unit.

• Innovates with new products like improved whitening, next-gen endodontic motors, and digital service models.

Financial objectives and performance

• Targets 3–5% organic sales growth per year, with EBIT margin rising from 8.1% (2023) to 13–15% by 2027.

• Plans to achieve >25% ROCE and maintain a 70% dividend payout ratio.

• Growth driven by portfolio changes, dedicated sales teams, and expansion in infection control and aesthetics.

• Operational efficiency initiatives include global procurement, productivity gains, and economies of scale.

• Strong financial structure and broad product portfolio support resilience and shareholder value creation.